D.E. Shaw & Co Portfolio holdings
D. E. Shaw & Co., L.P., founded in 1988 by David E. Shaw, a former Columbia University computer science professor, is a New York City-based global investment management firm renowned for pioneering quantitative investing, managing over $70 billion in assets as of late 2024. Starting with $28 million from Paloma Partners and private investors, the firm employs sophisticated mathematical models and proprietary algorithms—initially developed by a team of scientists and programmers—to exploit market anomalies across public and private markets, including equities, fixed income, and alternatives. Headquartered above a Greenwich Village bookstore in its early days, it now boasts over 2,500 employees across offices in North America, Europe, and Asia, led by a seven-member Executive Committee since Shaw stepped back in 2001 to focus on D. E. Shaw Research. Despite setbacks like the 1998 Russia debt crisis and the 2008 financial downturn, the firm has maintained a reputation for analytical rigor, risk management, and innovation, balancing its computational roots with discretionary strategies.
Top Buys
| Rank | Stock | Value |
|---|---|---|
| 1 |
ATVI
Activision Blizzard
ATVI
|
+$757M |
| 2 |
Alibaba
BABA
|
+$544M |
| 3 |
Booking.com
BKNG
|
+$475M |
| 4 |
XLNX
Xilinx Inc
XLNX
|
+$377M |
| 5 |
Caterpillar
CAT
|
+$285M |
Top Sells
| Rank | Stock | Value |
|---|---|---|
| 1 |
Apple
AAPL
|
+$1.07B |
| 2 |
Amazon
AMZN
|
+$486M |
| 3 |
Alphabet (Google) Class A
GOOGL
|
+$443M |
| 4 |
Salesforce
CRM
|
+$363M |
| 5 |
Qualcomm
QCOM
|
+$352M |
Sector Composition
| Rank | Sector | Weight |
|---|---|---|
| 1 | Technology | 14.27% |
| 2 | Consumer Discretionary | 9.91% |
| 3 | Healthcare | 7.11% |
| 4 | Financials | 6.94% |
| 5 | Communication Services | 6.17% |
| Name | Market Value | Portfolio Weight | Shares or Principal |
Change in Stake | Capital Flow | |
|---|---|---|---|---|---|---|
3326
Lemonade
LMND
$3.63B
| $1.18M | ﹤0.01% |
+17,561
| New | +$1.42M |
|
3327
TriSalus Life Sciences
TLSI
$268M
| $1.18M | ﹤0.01% |
+118,300
| New | +$1.16M |
|
3328
Inseego
INSG
$104M
| $1.17M | ﹤0.01% |
17,634
-8,953
| -34% | -$748K |
|
3329
Shinhan Financial Group
SHG
$32.3B
| $1.17M | ﹤0.01% |
34,711
+23,805
| +218% | +$796K |
|
|
MACU
3330
DELISTED
Mallard Acquisition Corp. Common stock
MACU
| $1.17M | ﹤0.01% |
117,218
+59,960
| +105% | +$594K |
|
3331
CALL
America's Car Mart
CRMT
$25.7M
| $1.17M | ﹤0.01% |
+10,000
| New | +$1.38M |
|
3332
Charles River Laboratories
CRL
$11.3B
| $1.17M | ﹤0.01% |
2,827
+1,985
| +236% | +$824K |
|
3333
CALL
D.R. Horton
DHI
$41.1B
| $1.17M | ﹤0.01% |
13,900
-81,900
| -85% | -$7.54M |
|
3334
CALL
Crocs
CROX
$6.61B
| $1.16M | ﹤0.01% |
+8,100
| New | +$1.11M |
|
3335
PUT
Motorola Solutions
MSI
$72B
| $1.16M | ﹤0.01% |
5,000
| – | – |
|
|
API
3336
CALL
Agora
API
$333M
| $1.16M | ﹤0.01% |
+40,000
| New | +$1.25M |
|
3337
N-able
NABL
$851M
| $1.16M | ﹤0.01% |
+93,396
| New | +$1.28M |
|
|
THCP
3338
DELISTED
Thunder Bridge Capital Partners IV, Inc. Class A Common Stock
THCP
| $1.16M | ﹤0.01% |
+119,232
| New | +$1.21M |
|
|
EBIX
3339
DELISTED
Ebix Inc
EBIX
| $1.16M | ﹤0.01% |
42,920
-20,239
| -32% | -$593K |
|
3340
KLA
KLAC
$225B
| $1.16M | ﹤0.01% |
34,540
+16,660
| +93% | +$556K |
|
3341
CALL
Ross Stores
ROST
$81.1B
| $1.15M | ﹤0.01% |
+10,600
| New | +$1.27M |
|
3342
US Physical Therapy
USPH
$1.21B
| $1.15M | ﹤0.01% |
10,425
+1,920
| +23% | +$219K |
|
3343
CALL
PennyMac Financial
PFSI
$4.47B
| $1.15M | ﹤0.01% |
18,800
-19,700
| -51% | -$1.25M |
|
|
ZNGA
3344
DELISTED
ZYNGA INC. CL A COMMON
ZNGA
| $1.15M | ﹤0.01% |
152,520
+91,561
| +150% | +$832K |
|
3345
PUT
Interactive Brokers
IBKR
$38.5B
| $1.15M | ﹤0.01% |
73,600
-139,200
| -65% | -$2.19M |
|
3346
Aclaris Therapeutics
ACRS
$714M
| $1.15M | ﹤0.01% |
63,622
-205,633
| -76% | -$3.3M |
|
3347
PUT
First Majestic Silver
AG
$7.54B
| $1.15M | ﹤0.01% |
101,300
+45,700
| +82% | +$590K |
|
3348
MiMedx Group
MDXG
$633M
| $1.15M | ﹤0.01% |
188,919
+161,326
| +585% | +$1.82M |
|
3349
8x8 Inc
EGHT
$281M
| $1.14M | ﹤0.01% |
48,904
-125,422
| -72% | -$3.14M |
|
3350
Evolution Petroleum
EPM
$133M
| $1.14M | ﹤0.01% |
201,433
-17,661
| -8% | -$78.9K |
|
Similar funds
D.E. Shaw & Co's Q3 2021 Portfolio in Review
As of Q3 2021, D.E. Shaw & Co held 5,618 positions worth $111B, down 4.4% from $116B the previous quarter. Its ten largest holdings account for 9.2% of the portfolio.
D.E. Shaw & Co withdrew a net $8.92B in Q3 2021, closing 695 positions and reducing 1,634 holdings. Its most notable exit was Alexion Pharmaceuticals, an estimated $228M position sold in full.
By sector, the portfolio is most concentrated in Technology at 14% of assets, down from 16% a quarter earlier, followed by Consumer Discretionary and Healthcare.
Against the trend, D.E. Shaw & Co opened a new position in Sea Limited worth $206M.
- D.E. Shaw & Co's largest Q3 2021 buy was Sea Limited: 645,697 shares worth $206M.
- D.E. Shaw & Co added most to Activision Blizzard in Q3 2021, an estimated $757M increase.
- D.E. Shaw & Co's biggest Q3 2021 reduction was Apple, cutting an estimated $1.07B.
- D.E. Shaw & Co fully exited Alexion Pharmaceuticals in Q3 2021, selling an estimated $228M.
- D.E. Shaw & Co's ten largest holdings make up 9.2% of its $111B portfolio in Q3 2021.
- D.E. Shaw & Co opened 915 new positions and closed 695 in Q3 2021.
- D.E. Shaw & Co's portfolio value fell 4.4% quarter-over-quarter to $111B.
Based on D.E. Shaw & Co's 13F filing for Q3 2021, filed 15 Nov 2021.